BAVENCIO conc perf 200 mg/10ml 4 flac 10 ml
7680663800020
CH-66380
L01FF04
07.16.1.
Reimbursement limitations:
BAVENCIO3
Le traitement nécessite une garantie de prise en charge des frais par la caisse d’assurance …
1 / 3
google
Details
- Product number
- 6638001
- CPT
- -
- Packaging group
- 4
- Unit
- Durchstechflasche(n)
- Composition
- avelumabum 200 mg, mannitolum, acidum aceticum glaciale, polysorbatum 20, natrii hydroxidum corresp. natrium 1.725 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml.
Articles (1)
Bavencio 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.725 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 3139.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2021
Authorization holder
Merck (Schweiz) AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 66380
- Drug name
- Bavencio, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FF04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/09/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BAVENCIO conc perf 200 mg/10ml 4 flac 10 ml
- Description (DE)
- BAVENCIO Inf Konz 200 mg/10ml 4 Durchstf 10 ml
- Market launch
- 05/09/2017
- Narcotic (BTM)
- No